<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Luo D</submitter><funding>China-Japan Friendship Hospital</funding><pagination>437</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12495665</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Accurate preoperative identification of high-risk pathological features in early-stage lung adenocarcinoma is critical for guiding surgical decisions and improving patient outcomes. This study aimed to develop and validate a nomogram to predict high-risk pathology in clinical stage IA lung adenocarcinoma located in the left upper lobe (LUL), an anatomical site with distinct surgical implications.&lt;h4>Methods&lt;/h4>We retrospectively reviewed 545 patients with clinical stage IA LUL adenocarcinoma who underwent surgery between January 2018 and May 2022. The cohort was randomly divided into training (80%) and validation (20%) sets. Independent predictors were identified via multivariate logistic regression and further validated using LASSO regression. A nomogram was constructe</pubmed_abstract><journal>BMC surgery</journal><pubmed_title>Development and validation of a nomogram for predicting high-risk pathology in clinical stage lA left upper lobe lung adenocarcinoma.</pubmed_title><pmcid>PMC12495665</pmcid><funding_grant_id>ZRJY2023-QM34</funding_grant_id><pubmed_authors>Liang C</pubmed_authors><pubmed_authors>Feng H</pubmed_authors><pubmed_authors>Yu Q</pubmed_authors><pubmed_authors>Su K</pubmed_authors><pubmed_authors>Han Y</pubmed_authors><pubmed_authors>Zhu W</pubmed_authors><pubmed_authors>Luo D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development and validation of a nomogram for predicting high-risk pathology in clinical stage lA left upper lobe lung adenocarcinoma.</name><description>&lt;h4>Background&lt;/h4>Accurate preoperative identification of high-risk pathological features in early-stage lung adenocarcinoma is critical for guiding surgical decisions and improving patient outcomes. This study aimed to develop and validate a nomogram to predict high-risk pathology in clinical stage IA lung adenocarcinoma located in the left upper lobe (LUL), an anatomical site with distinct surgical implications.&lt;h4>Methods&lt;/h4>We retrospectively reviewed 545 patients with clinical stage IA LUL adenocarcinoma who underwent surgery between January 2018 and May 2022. The cohort was randomly divided into training (80%) and validation (20%) sets. Independent predictors were identified via multivariate logistic regression and further validated using LASSO regression. A nomogram was constructe</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-06T13:38:36.518Z</modification><creation>2026-05-31T03:08:07.016Z</creation></dates><accession>S-EPMC12495665</accession><cross_references><pubmed>41044503</pubmed><doi>10.1186/s12893-025-03149-4</doi></cross_references></HashMap>